WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+6.72%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$3.05B
AUM Growth
+$3.05B
(+21%)
Cap. Flow
+$440M
Cap. Flow
% of AUM
14.43%
Top 10 Holdings %
Top 10 Hldgs %
28.17%
Holding
230
New
83
Increased
48
Reduced
47
Closed
52
Top Buys
| 1 |
Microchip Technology
MCHP
|
$72.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
$66.5M |
| 3 |
Amazon
AMZN
|
$65.6M |
| 4 |
Mastercard
MA
|
$63.4M |
| 5 |
Johnson & Johnson
JNJ
|
$61.5M |
Top Sells
| 1 |
Intel
INTC
|
$64.7M |
| 2 |
PayPal
PYPL
|
$52M |
| 3 |
eBay
EBAY
|
$48.4M |
| 4 |
NXP Semiconductors
NXPI
|
$42.9M |
| 5 |
Qorvo
QRVO
|
$42M |
Sector Composition
| 1 | Healthcare | 44.94% |
| 2 | Technology | 31.58% |
| 3 | Communication Services | 6.58% |
| 4 | Consumer Discretionary | 4.22% |
| 5 | Financials | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNCE
101
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $7.59M | 0.25% |
+929,651
| New | +$7.59M |
|
102
Regenxbio
RGNX
$498M
| $7.58M | 0.25% |
275,442
+133,731
| +94% | +$3.68M |
|
|
GLUU
103
DELISTED
Glu Mobile Inc.
GLUU
| $7.47M | 0.24% |
+973,123
| New | +$7.47M |
|
|
AKUS
104
DELISTED
Akouos, Inc. Common Stock
AKUS
| $7.45M | 0.24% |
325,831
+6,818
| +2% | +$156K |
|
105
PMV Pharmaceuticals
PMVP
$82.1M
| $7.36M | 0.24% |
+207,421
| New | +$7.36M |
|
106
Wolfspeed
WOLF
$203M
| $7.32M | 0.24% |
+114,780
| New | +$7.32M |
|
107
Avnet
AVT
$4.38B
| $7.25M | 0.24% |
280,596
+120,138
| +75% | +$3.1M |
|
|
LEAP.U
108
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $6.71M | 0.22% |
+516,400
| New | +$6.71M |
|
|
IGMS
109
DELISTED
IGM Biosciences
IGMS
| $6.67M | 0.22% |
+90,378
| New | +$6.67M |
|
110
Iovance Biotherapeutics
IOVA
$800M
| $6.54M | 0.21% |
+198,684
| New | +$6.54M |
|
111
Silicon Laboratories
SLAB
$4.3B
| $6.32M | 0.21% |
64,581
+13,659
| +27% | +$1.34M |
|
112
Outset Medical
OM
$245M
| $6.28M | 0.21% |
+125,584
| New | +$6.28M |
|
113
American Well
AMWL
$112M
| $6.27M | 0.21% |
+211,666
| New | +$6.27M |
|
|
INFN
114
DELISTED
Infinera Corporation Common Stock
INFN
| $6.17M | 0.2% |
1,001,608
+913,554
| +1,037% | +$5.63M |
|
115
Annexon
ANNX
$225M
| $6.07M | 0.2% |
+200,738
| New | +$6.07M |
|
|
ATNX
116
DELISTED
Athenex, Inc. Common Stock
ATNX
| $6.05M | 0.2% |
+500,000
| New | +$6.05M |
|
|
SYNH
117
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $6.01M | 0.2% |
+113,119
| New | +$6.01M |
|
118
AMN Healthcare
AMN
$760M
| $5.95M | 0.19% |
101,744
-147,193
| -59% | -$8.6M |
|
|
CHMA
119
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $5.71M | 0.19% |
1,328,257
+908,521
| +216% | +$3.91M |
|
120
Ciena
CIEN
$13.4B
| $5.54M | 0.18% |
+139,676
| New | +$5.54M |
|
|
CVET
121
DELISTED
Covetrus, Inc. Common Stock
CVET
| $5.52M | 0.18% |
+226,378
| New | +$5.52M |
|
122
Prelude Therapeutics
PRLD
$69.1M
| $5.4M | 0.18% |
+179,361
| New | +$5.4M |
|
123
Dyne Therapeutics
DYN
$1.92B
| $5.39M | 0.18% |
+266,799
| New | +$5.39M |
|
124
Kymera Therapeutics
KYMR
$3.1B
| $5.37M | 0.18% |
+166,217
| New | +$5.37M |
|
125
TG Therapeutics
TGTX
$5.03B
| $5.35M | 0.18% |
199,875
-132,777
| -40% | -$3.55M |
|